BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8884537)

  • 1. Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus.
    Salgado LR; Semer M; Nery M; Knoepfelmacher M; Lerário AC; Póvoa G; Jana S; Villares SM; Wajchenberg BL; Liberman B; Nicolau W
    J Endocrinol Invest; 1996; 19(7):433-40. PubMed ID: 8884537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of pubertal status and glycemic control on the growth hormone-IGF-I axis in boys with insulin-dependent diabetes mellitus.
    Clark PA; Clarke WL; Pedadda S; Reiss A; Langlois C; Nieves-Rivera F; Rogol AD
    J Pediatr Endocrinol Metab; 1998; 11(3):427-35. PubMed ID: 11517959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
    Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of IGF binding protein-1 in the dawn phenomenon and glycemic control in children and adolescents with IDDM.
    Kobayashi K; Amemiya S; Sawanobori E; Higashida K; Ishihara T; Kobayashi K; Kato K; Nakazawa S
    Diabetes Care; 1997 Sep; 20(9):1442-7. PubMed ID: 9283794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion.
    Shishko PI; Dreval AV; Abugova IA; Zajarny IU; Goncharov VC
    Diabetes Res Clin Pract; 1994 Aug; 25(1):1-12. PubMed ID: 7530621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Effects of Intraperitoneal and Subcutaneous Insulin Administration on the GH-IGF-1 Axis in Type 1 Diabetes.
    van Dijk PR; Logtenberg SJ; Chisalita SI; Hedman CA; Groenier KH; Gans RO; Kleefstra N; Arnqvist HJ; Bilo HJ
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2493-501. PubMed ID: 27115061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
    Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of growth hormone-binding protein in altered GH-IGF axis in IDDM.
    Kobayashi K; Amemiya S; Kobayashi K; Sawanobori E; Mochizuki M; Ishihara T; Higashida K; Miura M; Nakazawa S
    Endocr J; 1999 Mar; 46 Suppl():S67-9. PubMed ID: 12054124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous positive airway pressure increases pulsatile growth hormone secretion and circulating insulin-like growth factor-1 in a time-dependent manner in men with obstructive sleep apnea: a randomized sham-controlled study.
    Hoyos CM; Killick R; Keenan DM; Baxter RC; Veldhuis JD; Liu PY
    Sleep; 2014 Apr; 37(4):733-41. PubMed ID: 24899762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment.
    Halldin MU; Brismar K; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):735-43. PubMed ID: 12460323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous and stimulated growth hormone release in adolescents with type I diabetes mellitus: effects of metabolic control.
    Miller JD; Wright NM; Lester SE; Felsing NE; Linzer J; Chan E; White DA; Charles MA
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1087-91. PubMed ID: 1400876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a high-protein diet on ghrelin, growth hormone, and insulin-like growth factor-I and binding proteins 1 and 3 in subjects with type 2 diabetes mellitus.
    Gannon MC; Nuttall FQ
    Metabolism; 2011 Sep; 60(9):1300-11. PubMed ID: 21406307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes.
    Hedman CA; Frystyk J; Lindström T; Chen JW; Flyvbjerg A; Ørskov H; Arnqvist HJ
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6305-9. PubMed ID: 15579794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects.
    Ismail IS; Miell JP; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):147-52. PubMed ID: 7535669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A; Lang CH; Blethen SL; Gelato MC; Fan J; Frost RA; Wilson TA
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation in serum free ultrafiltrable insulin-like growth factor I concentrations in healthy children.
    Heuck C; Skjaerbaek C; Orskov H; Wolthers OD
    Pediatr Res; 1999 May; 45(5 Pt 1):733-6. PubMed ID: 10231873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
    Hilding A; Brismar K; Degerblad M; Thorén M; Hall K
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM.
    Hanaire-Broutin H; Sallerin-Caute B; Poncet MF; Tauber M; Bastide R; Chalé JJ; Rosenfeld R; Tauber JP
    Diabetologia; 1996 Dec; 39(12):1498-504. PubMed ID: 8960832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.